Treat your GLP-1 like groceries that must stay cold, because functionally that is what it is
The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD
Additionally, it affects a broader population, including non-diabetic individuals using these medications for weight loss
Your PCP can order and interpret comprehensive lab work, monitor for interactions with other medications, and provide a medical home that your telehealth provider cannot fully replace
Many patients find that after losing weight, they want to improve skin tone, tighten sagging areas, or enhance facial features to align with their new, healthier body
As for side effects, clients typically experience a few days of redness and some dryness